Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Never take more than your prescribed dose
In a post-hoc analysis of the SURPASS-4 trial, tirzepatide decreased albuminuria (protein in urine, a marker of kidney damage) and nearly halved the risk of a composite kidney endpoint compared to insulin glargine
Monday at 8 PM to Thursday at 8 AM is not 72 hours
Quality, sourcing, and medical oversight matter because the gut is not an isolated organ
Patients should be advised to report any suspected side effects via the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk or the Yellow Card app)
Wegovy 2.4mg FlexTouch By Novo Nordisk India Pvt Ltd All prices are inclusive of taxes Dosage 2.4mg Pack Size 1 Pen of 3ml Active Ingredient/Salt Semaglutide Product Description Wegovy 2.4 mg FlexTouch contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist indicated for chronic weight management in adults who are overweight or obese, and for reducing the risk of major cardiovascular events such as heart attack or stroke in adults with established heart disease and excess weight
